Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.07 | 0.04 | 0.00 | 0.16 | 0.21 | 0.22 | 0.26 | 0.09 | 0.09 | 0.05 | 0.04 | 0.04 |
| Expenses | 0.05 | 0.02 | 0.04 | 0.03 | 0.07 | 0.06 | 0.26 | 0.06 | 0.09 | 0.04 | 0.04 | 0.02 |
| Operating Profit | 0.02 | 0.02 | -0.04 | 0.13 | 0.14 | 0.16 | 0.00 | 0.03 | 0.00 | 0.01 | 0.00 | 0.02 |
| OPM % | 28.57% | 50.00% | 81.25% | 66.67% | 72.73% | 0.00% | 33.33% | 0.00% | 20.00% | 0.00% | 50.00% | |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.02 | 0.02 | -0.04 | 0.13 | 0.15 | 0.16 | 0.00 | 0.03 | 0.00 | 0.01 | 0.00 | 0.02 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||
| Net Profit | 0.02 | 0.02 | -0.04 | 0.13 | 0.15 | 0.16 | -0.08 | 0.02 | 0.00 | 0.01 | -0.01 | 0.01 |
| EPS in Rs | 0.07 | 0.07 | -0.13 | 0.43 | 0.49 | 0.52 | -0.26 | 0.07 | 0.00 | 0.03 | -0.03 | 0.03 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.11 | 0.44 | 0.59 | 0.99 | 0.85 | 0.21 | 0.07 | 2.72 | 0.17 | 0.84 | 0.27 | 0.22 |
| Expenses | 0.54 | 0.48 | 0.49 | 0.57 | 0.30 | 0.34 | 0.45 | 1.84 | 0.15 | 0.40 | 0.23 | 0.19 |
| Operating Profit | -0.43 | -0.04 | 0.10 | 0.42 | 0.55 | -0.13 | -0.38 | 0.88 | 0.02 | 0.44 | 0.04 | 0.03 |
| OPM % | -390.91% | -9.09% | 16.95% | 42.42% | 64.71% | -61.90% | -542.86% | 32.35% | 11.76% | 52.38% | 14.81% | 13.64% |
| Other Income | 0.16 | 0.01 | 0.03 | 0.01 | 0.01 | 0.00 | 0.50 | -0.22 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.02 | 0.00 | 0.00 | 0.00 | 0.18 | 0.18 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.05 | 0.04 | 0.08 | 0.19 | 0.18 | 0.19 | 0.08 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.34 | -0.07 | 0.05 | 0.24 | 0.20 | -0.50 | 0.00 | 0.65 | 0.02 | 0.44 | 0.04 | 0.03 |
| Tax % | -2.94% | 0.00% | 40.00% | 0.00% | -40.00% | 12.00% | 0.00% | 0.00% | 20.45% | 25.00% | ||
| Net Profit | -0.33 | -0.07 | 0.03 | 0.23 | 0.29 | -0.56 | -0.01 | 0.65 | 0.02 | 0.36 | 0.03 | 0.01 |
| EPS in Rs | -1.08 | -0.23 | 0.10 | 0.75 | 0.95 | -1.83 | -0.03 | 2.13 | 0.07 | 1.18 | 0.10 | 0.03 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 9% | 5% | -54% | -72% | ||
| Compounded Profit Growth | 8% | 15% | -68% | -96% | ||
| Stock Price CAGR | % | 5% | 7% | -19% | ||
| Return on Equity | 2% | 5% | 4% | 1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 |
| Reserves | 1.84 | 1.51 | 1.44 | 1.47 | 1.71 | 1.99 | 1.43 | -0.18 | 0.47 | 0.49 | 0.84 | 0.87 |
| Borrowings | 0.75 | 0.75 | 0.75 | 0.75 | 1.48 | 1.48 | 1.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.80 | 0.73 | 0.78 | 1.41 | 0.94 | 1.49 | 1.59 | 0.92 | 0.90 | 0.79 | 0.47 | 0.33 |
| Total Liabilities | 6.44 | 6.04 | 6.02 | 6.68 | 7.18 | 8.01 | 7.62 | 3.79 | 4.42 | 4.33 | 4.36 | 4.25 |
| Fixed Assets | 3.15 | 3.18 | 3.63 | 4.12 | 4.31 | 4.47 | 5.86 | 1.75 | 0.00 | 0.00 | 0.01 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.38 | 0.49 | 0.49 | 0.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.55 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Other Assets | 2.74 | 2.75 | 2.39 | 2.18 | 2.38 | 3.05 | 1.27 | 2.04 | 4.42 | 4.31 | 4.35 | 4.25 |
| Total Assets | 6.44 | 6.04 | 6.02 | 6.68 | 7.18 | 8.01 | 7.62 | 3.79 | 4.42 | 4.33 | 4.36 | 4.25 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0.09 | -0.69 | 0.35 | 0.87 | -1.04 | 0.44 | 1.48 | -2.13 | -0.78 | -0.02 | 0.03 | -0.02 |
| Cash from Investing Activity | -0.65 | 0.53 | -0.31 | -0.91 | 0.37 | -0.47 | -1.58 | 3.67 | 1.52 | -0.02 | 0.01 | 0.00 |
| Cash from Financing Activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.73 | 0.00 | 0.07 | -1.55 | -0.70 | 0.00 | 0.00 | 0.00 |
| Net Cash Flow | -0.56 | -0.16 | 0.04 | -0.04 | 0.06 | -0.04 | -0.03 | -0.01 | 0.04 | -0.04 | 0.04 | -0.02 |
| Free Cash Flow | -0.05 | -0.77 | -0.15 | -0.07 | -0.68 | -0.04 | -0.10 | 3.22 | 0.70 | -0.02 | 0.02 | -0.02 |
| CFO/OP | -225% | 160% | -875% | 870% | -248% | 80% | -1,138% | 561% | -89% | -100% | 27% | -25% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 12.37 | 22.12 | 42.94 | 104.29 | 0.00 | 297.90 | 5,432.06 | 960.30 | 3,136.30 |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 486.67 | |||||||
| Days Payable | 17.38 | |||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 12.37 | 22.12 | 42.94 | 104.29 | 0.00 | 297.90 | 5,432.06 | 1,429.58 | 3,136.30 |
| Working Capital Days | -8,881.67 | -1,659.09 | -514.32 | -804.24 | 55.30 | -176.06 | -1,251.43 | 4,849.29 | 221.42 | 4,530.29 | 916.85 | 3,176.85 |
| ROCE % | 0.35% | -5.84% | -0.57% | 0.57% | 4.17% | 5.96% | -5.10% | -8.54% | 28.48% | 0.57% | 11.84% | 1.02% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 66.32% | 65.04% | 64.20% | 64.14% | 54.67% | 46.83% | 46.78% | 46.72% | 46.72% | 46.06% | 46.06% | 46.06% |
| Public | 33.68% | 34.96% | 35.80% | 35.86% | 45.33% | 53.16% | 53.20% | 53.28% | 53.29% | 53.94% | 53.94% | 53.94% |
| No. of Shareholders | 591 | 1,014 | 1,334 | 1,540 | 2,128 | 2,497 | 2,504 | 2,460 | 2,459 | 2,522 | 2,481 | 2,448 |
Fundamentals
Market Cap₹ 8.86 Cr.
Current Price₹ 29.0
Stock P/E886
Book Value₹ 12.8
ROCE1.02 %
ROE0.77 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-72%
Compounded Profit Growth (TTM)-96%
Standalone figures.
Valuation
Market capRs 9 Cr
Enterprise valueRs 9 Cr
P/E (TTM)294.11x
Price to book2.25x
Price to sales40.11x
EV / EBITDA219.83x
EV / EBIT219.83x
EV / sales39.97x
Earnings yield0.34%
P/E, 3-year average289.91x
P/B, 3-year average3.80x
P/E, 5-year average196.68x
P/B, 5-year average3.03x
Profitability
Operating margin (excl. other income)14.81%
Operating margin (incl. other income)14.81%
EBITDA margin18.18%
Pre-tax margin18.18%
Net profit margin13.64%
Net margin, latest quarter25.00%
ROE0.77%
ROCE1.02%
ROA0.70%
ROE, 3-year average3.68%
ROCE, 3-year average4.48%
ROA, 3-year average3.15%
ROE, 5-year average6.22%
ROCE, 5-year average8.44%
ROA, 5-year average5.02%
ROIC (approx.)0.77%
Tax rate25.00%
Growth
Sales growth (latest year)-67.86%
Profit growth (latest year)-91.67%
Sales CAGR, 3 years-53.70%
Sales CAGR, 5 years5.15%
Profit CAGR, 3 years-64.13%
Sales growth QoQ0.00%
Sales growth YoY (latest quarter)-55.56%
Profit growth YoY (latest quarter)-50.00%
Per share
EPS (TTM)Rs 0.10
EPS (latest quarter)Rs 0.03
EPS, 3-year averageRs 0.62
EPS, 5-year averageRs 0.83
Book value per shareRs 12.83
Sales per shareRs 0.72
Cash flow per shareRs -0.07
Free cash flow per shareRs -0.07
Efficiency
Asset turnover0.06x
Inventory turnover0.00x
Debtor days3136 days
Debtors turnover0.12x
Creditor days17 days
Cash conversion cycle3136 days
Working capital days3177 days
Leverage
Cash and bankRs 0 Cr
Net debtRs -0 Cr
Net debt / EBITDA-0.75x
Owners' fund to total sources92.24%
Cash flow
Cash from Operating Activity (latest year)Rs -0 Cr
Net Cash Flow (latest year)Rs -0 Cr
Free cash flow (latest year)Rs -0 Cr
Cash from ops / profit, 5 years-2.78x
Statement figures
Net sales (TTM)Rs 0 Cr
Net sales (latest year)Rs 0 Cr
Sales (latest quarter)Rs 0 Cr
Operating profit excl. other income (latest year)Rs 0 Cr
Operating profit (latest quarter)Rs 0 Cr
EBITDA (TTM)Rs 0 Cr
PBDT (TTM)Rs 0 Cr
Profit before tax (TTM)Rs 0 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs 0 Cr
Net profit (latest quarter)Rs 0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total expenditure (latest year)Rs 0 Cr
Total income (latest year)Rs 0 Cr
Share capitalRs 3 Cr
ReservesRs 1 Cr
Shareholders' fundsRs 4 Cr
Total assetsRs 4 Cr
ReceivablesRs 2 Cr
InventoryRs 0 Cr
Other liabilitiesRs 0 Cr
Shares outstanding (crore)0.31
Ownership
Promoter holding46.06% (-0.66 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 294.1 is at the 92th percentile of its own 3.2-year range
(median 23.7, low 10.2, high 309.4).
P/B 2.25 is at the 44th percentile (median 2.33).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 539206 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -4.5% | -2.8% | -1.7 pts |
| 1 month | -9.2% | -6.8% | -2.4 pts |
| 3 months | -17.7% | -7.6% | -10.1 pts |
| 3 years | +20.6% | +14.2% | +6.4 pts |
| 5 years | +28.4% | +27.9% | +0.5 pts |
Red flags
F-score 3 of 8| explain | Weak cash conversion Cash from operations was -2% of net profit over the last 3 years |
| explain | Receivables outrunning sales Receivables grew 5% vs sales -68% in 2026 |
| look | Inventory outrunning sales Inventory grew 0% vs sales -68% in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹0 Cr -55.6% vs Jun 2025.
Net profit ₹0 Cr -50.0%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Anthem Biosciences Ltd | 48,996 | 82.6 | 30.4 % |
| Advanced Enzyme Technologies Ltd | 3,152 | 20.0 | 14.0 % |
| CCME Global Ltd | 208 | -2.92 % | |
| Vivo Bio Tech Ltd | 36 | 7.74 % | |
| Shree Ganesh Biotech India Ltd | 19 | 1.31 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Genomic Valley Biotech Ltd?
Genomic Valley Biotech Ltd (539206) has a market capitalisation of Rs 8.86 Cr. at the 2026-10-01 close.
What is the P/E ratio of Genomic Valley Biotech Ltd?
Genomic Valley Biotech Ltd trades at a P/E of 886 on trailing twelve-month profit, at the 2026-10-01 close.
What were Genomic Valley Biotech Ltd's latest quarterly results?
In the Jun 2026 quarter, Genomic Valley Biotech Ltd sales was Rs 0 Cr (-55.6% vs Jun 2025) and net profit was Rs 0 Cr.